FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.4-SNAPSHOT  |  FHIR Version n/a  User: [n/a]

373692009: Substance with phosphodiesterase inhibitor mechanism of action (substance)


Status: current, Sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jan 2018. Module: SNOMED CT core

Descriptions:

Id Description Lang Type Status Case? Module
1212151018 Phosphodiesterase inhibitor en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core
3520795018 Substance with phosphodiesterase inhibitor mechanism of action (substance) en Fully specified name Active Entire term case insensitive (core metadata concept) SNOMED CT core
3520964015 Substance with phosphodiesterase inhibitor mechanism of action en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core
1198992010 Phosphodiesterase inhibitor (substance) en Fully specified name Active Only initial character case insensitive (core metadata concept) SNOMED CT core
1198992010 Phosphodiesterase inhibitor (substance) en Fully specified name Active Entire term case insensitive (core metadata concept) SNOMED CT core
1212151018 Phosphodiesterase inhibitor en Synonym (core metadata concept) Active Only initial character case insensitive (core metadata concept) SNOMED CT core
1212151018 Phosphodiesterase inhibitor en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core
3520795018 Substance with phosphodiesterase inhibitor mechanism of action (substance) en Fully specified name Active Entire term case insensitive (core metadata concept) SNOMED CT core
3520964015 Substance with phosphodiesterase inhibitor mechanism of action en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core
188931000077117 inhibiteur de la phosphodiestérase fr Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT Switzerland NRC maintained Module
188931000077117 inhibiteur de la phosphodiestérase fr Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT Switzerland NRC maintained Module


39 descendants. Search Descendants:

Expanded Value Set


Outbound Relationships Type Target Active Characteristic Refinability Group Values
Phosphodiesterase inhibitor Is a Inotropic agent (substance) false Inferred relationship Existential restriction modifier (core metadata concept)
Phosphodiesterase inhibitor Is a Enzyme inhibitor false Inferred relationship Existential restriction modifier (core metadata concept)
Phosphodiesterase inhibitor Is a Substance with hydrolase inhibitor mechanism of action (substance) true Inferred relationship Existential restriction modifier (core metadata concept)
Phosphodiesterase inhibitor Has disposition Phosphodiesterase inhibitor (disposition) true Inferred relationship Existential restriction modifier (core metadata concept)

Inbound Relationships Type Active Source Characteristic Refinability Group
Product containing aspirin and butalbital and caffeine (medicinal product) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Phosphodiesterase inhibitor Inferred relationship Existential restriction modifier (core metadata concept)
Aminophylline hydrate 350mg modified-release tablet The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Phosphodiesterase inhibitor Inferred relationship Existential restriction modifier (core metadata concept)
Aminophylline hydrate 225mg modified-release tablet The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Phosphodiesterase inhibitor Inferred relationship Existential restriction modifier (core metadata concept)
Aminophylline hydrate 100mg modified-release tablets The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Phosphodiesterase inhibitor Inferred relationship Existential restriction modifier (core metadata concept)
Amrinone (substance) Is a False Phosphodiesterase inhibitor Inferred relationship Existential restriction modifier (core metadata concept)
Product containing precisely aspirin 250 milligram and caffeine 65 milligram and paracetamol 250 milligram/1 each conventional release oral tablet (clinical drug) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Phosphodiesterase inhibitor Inferred relationship Existential restriction modifier (core metadata concept)
Ergotamine + caffeine The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Phosphodiesterase inhibitor Inferred relationship Existential restriction modifier (core metadata concept)
Accidental phosphodiesterase inhibitor poisoning Causative agent (attribute) True Phosphodiesterase inhibitor Inferred relationship Existential restriction modifier (core metadata concept) 2
Intentional phosphodiesterase inhibitor poisoning Causative agent (attribute) True Phosphodiesterase inhibitor Inferred relationship Existential restriction modifier (core metadata concept) 2
Caffeine 65 mg and paracetamol 500 mg oral tablet The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Phosphodiesterase inhibitor Inferred relationship Existential restriction modifier (core metadata concept)
Product containing precisely caffeine 30 milligram and paracetamol 450 milligram/1 each conventional release oral tablet (clinical drug) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Phosphodiesterase inhibitor Inferred relationship Existential restriction modifier (core metadata concept)
Caffeine 25 mg and paracetamol 450 mg oral tablet The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Phosphodiesterase inhibitor Inferred relationship Existential restriction modifier (core metadata concept)
Caffeine- and paracetamol-containing product The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Phosphodiesterase inhibitor Inferred relationship Existential restriction modifier (core metadata concept)
Paracetamol+caffeine 500mg/65mg soluble tablet (substance) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Phosphodiesterase inhibitor Inferred relationship Existential restriction modifier (core metadata concept)
Product containing caffeine and ergotamine (medicinal product) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Phosphodiesterase inhibitor Inferred relationship Existential restriction modifier (core metadata concept)
Caffeine Is a True Phosphodiesterase inhibitor Inferred relationship Existential restriction modifier (core metadata concept)
Roflumilast (substance) Is a False Phosphodiesterase inhibitor Inferred relationship Existential restriction modifier (core metadata concept)
Phosphodiesterase 4 inhibitor Is a True Phosphodiesterase inhibitor Inferred relationship Existential restriction modifier (core metadata concept)
Theophylline anhydrous Is a True Phosphodiesterase inhibitor Inferred relationship Existential restriction modifier (core metadata concept)
Theophylline sodium glycinate Is a True Phosphodiesterase inhibitor Inferred relationship Existential restriction modifier (core metadata concept)
Theophylline sodium acetate (substance) Is a True Phosphodiesterase inhibitor Inferred relationship Existential restriction modifier (core metadata concept)
Theophylline monohydrate Is a True Phosphodiesterase inhibitor Inferred relationship Existential restriction modifier (core metadata concept)
Theophylline calcium salicylate Is a True Phosphodiesterase inhibitor Inferred relationship Existential restriction modifier (core metadata concept)
Choline theophyllinate (substance) Is a True Phosphodiesterase inhibitor Inferred relationship Existential restriction modifier (core metadata concept)
Caffeine citrate (substance) Is a True Phosphodiesterase inhibitor Inferred relationship Existential restriction modifier (core metadata concept)
Caffeine hydrate (substance) Is a True Phosphodiesterase inhibitor Inferred relationship Existential restriction modifier (core metadata concept)
Milrinone lactate Is a False Phosphodiesterase inhibitor Inferred relationship Existential restriction modifier (core metadata concept)
Caffeine monohydrate (substance) Is a True Phosphodiesterase inhibitor Inferred relationship Existential restriction modifier (core metadata concept)
Papaverine (substance) Is a True Phosphodiesterase inhibitor Inferred relationship Existential restriction modifier (core metadata concept)
Papaveretum (substance) Is a True Phosphodiesterase inhibitor Inferred relationship Existential restriction modifier (core metadata concept)
Papaverine hydrochloride Is a True Phosphodiesterase inhibitor Inferred relationship Existential restriction modifier (core metadata concept)
Allergy to phosphodiesterase inhibitor (finding) Causative agent (attribute) True Phosphodiesterase inhibitor Inferred relationship Existential restriction modifier (core metadata concept) 1
Amrinone lactate Is a False Phosphodiesterase inhibitor Inferred relationship Existential restriction modifier (core metadata concept)
Doxofylline Is a True Phosphodiesterase inhibitor Inferred relationship Existential restriction modifier (core metadata concept)
Substance with phosphodiesterase 3 inhibitor mechanism of action (substance) Is a True Phosphodiesterase inhibitor Inferred relationship Existential restriction modifier (core metadata concept)
Caffeine anhydrous Is a True Phosphodiesterase inhibitor Inferred relationship Existential restriction modifier (core metadata concept)

Start Page 2 of 2


This concept is not in any reference sets

Back to Start